RU2002128481A - METHOD FOR OBTAINING PURIFIED ACTIVATED FACTOR X BLOOD COAGING - Google Patents
METHOD FOR OBTAINING PURIFIED ACTIVATED FACTOR X BLOOD COAGINGInfo
- Publication number
- RU2002128481A RU2002128481A RU2002128481/15A RU2002128481A RU2002128481A RU 2002128481 A RU2002128481 A RU 2002128481A RU 2002128481/15 A RU2002128481/15 A RU 2002128481/15A RU 2002128481 A RU2002128481 A RU 2002128481A RU 2002128481 A RU2002128481 A RU 2002128481A
- Authority
- RU
- Russia
- Prior art keywords
- sodium
- sepharose
- column
- obtaining purified
- sodium citrate
- Prior art date
Links
- 108010074860 Factor Xa Proteins 0.000 title claims 2
- 210000004369 Blood Anatomy 0.000 title 1
- 239000008280 blood Substances 0.000 title 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K Trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 4
- 239000001509 sodium citrate Substances 0.000 claims 3
- 239000011778 trisodium citrate Substances 0.000 claims 3
- 102100001249 ALB Human genes 0.000 claims 2
- 101710027066 ALB Proteins 0.000 claims 2
- WDIHJSXYQDMJHN-UHFFFAOYSA-L Barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 claims 2
- 229920002271 DEAE-Sepharose Polymers 0.000 claims 2
- 102100015239 F2 Human genes 0.000 claims 2
- 229940093429 Polyethylene Glycol 6000 Drugs 0.000 claims 2
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 claims 2
- 108010094028 Prothrombin Proteins 0.000 claims 2
- 229940039716 Prothrombin Drugs 0.000 claims 2
- 229940050528 albumin Drugs 0.000 claims 2
- 229910001626 barium chloride Inorganic materials 0.000 claims 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000000047 product Substances 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 239000003381 stabilizer Substances 0.000 claims 2
- 108010014173 Factor X Proteins 0.000 claims 1
- 210000002381 Plasma Anatomy 0.000 claims 1
- 229920002684 Sepharose Polymers 0.000 claims 1
- 238000010828 elution Methods 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 238000001556 precipitation Methods 0.000 claims 1
- 229960002668 sodium chloride Drugs 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000002821 viper venom Substances 0.000 claims 1
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2002128481/15A RU2221578C1 (en) | 2002-10-24 | 2002-10-24 | Method for producing purified activated blood coagulation x-factor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2002128481/15A RU2221578C1 (en) | 2002-10-24 | 2002-10-24 | Method for producing purified activated blood coagulation x-factor |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2221578C1 RU2221578C1 (en) | 2004-01-20 |
RU2002128481A true RU2002128481A (en) | 2004-04-27 |
Family
ID=32091783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002128481/15A RU2221578C1 (en) | 2002-10-24 | 2002-10-24 | Method for producing purified activated blood coagulation x-factor |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2221578C1 (en) |
-
2002
- 2002-10-24 RU RU2002128481/15A patent/RU2221578C1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1755652B1 (en) | Factor ixa for the treatment of bleeding disorders | |
JP3701028B2 (en) | How to obtain high purity von Willebrand factor | |
EP0352903B1 (en) | Bovine factor Xa inhibiting factor and pharmaceutical compositions containing the same | |
EP0317376A1 (en) | Preparation of a concentrate of high-purity human factor IX and of other plasma proteins | |
US4022758A (en) | Isolation of coagulation factors I and VIII from biological material | |
JPH04504264A (en) | Inhibition of tumor growth by blocking the protein C system | |
JP2004522707A (en) | Method for producing latent antithrombin III | |
JPH0424360B2 (en) | ||
PL82807B1 (en) | ||
CA1211371A (en) | Method of producing an antithrombin iii-heparin concentrate or an antithrombin iii-heparinoid concentrate | |
JPH09503775A (en) | Method for preparing inter-α-trypsin inhibitor concentrate for use in therapy and concentrate thus obtained | |
EP0652900B1 (en) | Thrombin inhibitors | |
US4473553A (en) | Process for producing a lipoprotein-poor concentrate of coagulation factors VII and VIIa | |
US5712247A (en) | Use of lactoferrin to modulate and/or neutralize heparin activity | |
AU2003213863B2 (en) | Prothrombin activating protein | |
RU2002128481A (en) | METHOD FOR OBTAINING PURIFIED ACTIVATED FACTOR X BLOOD COAGING | |
Nahas et al. | Effect of heparin on the coagulant action of snake venoms | |
JPH08510212A (en) | Hookworm anticoagulant | |
Svoboda et al. | Purification and characterization of three α2-antiplasmin and α2-macroglobulin inactivating enzymes from the venom of the Mexican west coast rattlesnake (Crotalus basiliscus) | |
CA2124161C (en) | Pharmaceuticals for treating sepsis and septic shock | |
JPS6379835A (en) | Production of plasminogen activator | |
JPH08782B2 (en) | Anti-inflammatory agent | |
JPH07291999A (en) | Platelet stabilization factor ix-fragment, its production, and chemical containing it | |
AU1042597A (en) | Potentiation of complement and coagulation inhibitory properties of c1-inhibitor. | |
KR950013455B1 (en) | Method of purification of purified human blood coagulation factor ñœand ñ© |